Whalegun
Home

Ultragenyx Pharmaceutical RARE spent $80K on lobbying in Q3 2024 · Health Issues, Budget and 1 more issue

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q3 2024
Stock
Ultragenyx Pharmaceutical RARE
Client
Ultragenyx Pharmaceutical
Reported
24/10/21

Up 166.7% from last quarter

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Ultragenyx Pharmaceutical's other lobbying reports